Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS)

Clinica Chimica Acta

Volumn 355, Issue 1-2, 2005, Pages 211-213

  Wilson, David H ^a   Sepe, Dinia ^a   Barnes, Grady ^a   Johnston, Fran ^b  

^a ABBOTT LABORATORIES   (United States)

^b Shield Diagnostics Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

AREA UNDER THE CURVE; BLOOD SAMPLING; ERYTHROCYTE; GERMANY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY TEST; LETTER; MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; UNITED STATES;

EID: 17044434310     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.01.005     Document Type: Letter

References (5)

1. K.L. Napoli, and B.D. Kahan Sample clean-up and high performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations J Chromatogr B Analyt Technol Biomed Life Sci 654 1994 111 120
2. K.L. Napoli, and B.D. Kahan Routine clinical monitoring of sirolimus (rapamycin) whole blood concentrations by HPLC with ultraviolet detection Clin Chem 42 1996 1943 1948
3. P.J. Taylor, and A.G. Johnson Quantitative analysis of sirolimus (rapamycin) in blood by high-performance liquid chromatography-electrospray tandem mass spectrometry J Chromatogr 718 1998 251 257
4. D.W. Holt, T. Lee, K. Jones, and A. Johnston Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection Clin Chem 46 2000 1179 1183
5. D.W. Holt, T. Lee, and A. Johnston Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection Clin Ther 22 Suppl. B 2000 B38 B48